rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1986-8-15
|
pubmed:abstractText |
The binding of D-[3H]aspartic acid to the high-affinity glutamate uptake system was studied in membrane preparations of postmortem brains from controls and Huntington's disease (HD) subjects. The groups were matched for age and postmortem delay. A large (60-72%) and significant reduction in D-[3H]aspartate binding was observed in both the caudate nucleus and putamen, but not in the frontal cortex of the HD brains. The loss of striatal D-[3H]aspartate binding may reflect a loss of the high-affinity glutamate uptake system contained on the terminals of corticostriatal afferents. In contrast, the binding of [3H]paroxetine to the serotonin uptake system was marginally increased in the caudate nucleus and unchanged in the putamen. It is suggested that the reduction of high-affinity glutamate uptake sites may contribute to the production of the striatal lesion in HD.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0304-3940
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
18
|
pubmed:volume |
67
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
198-202
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2873534-Aged,
pubmed-meshheading:2873534-Aspartic Acid,
pubmed-meshheading:2873534-Brain,
pubmed-meshheading:2873534-Caudate Nucleus,
pubmed-meshheading:2873534-Female,
pubmed-meshheading:2873534-Frontal Lobe,
pubmed-meshheading:2873534-Glutamates,
pubmed-meshheading:2873534-Glutamic Acid,
pubmed-meshheading:2873534-Hippocampus,
pubmed-meshheading:2873534-Humans,
pubmed-meshheading:2873534-Huntington Disease,
pubmed-meshheading:2873534-Male,
pubmed-meshheading:2873534-Middle Aged,
pubmed-meshheading:2873534-Paroxetine,
pubmed-meshheading:2873534-Piperidines,
pubmed-meshheading:2873534-Putamen
|
pubmed:year |
1986
|
pubmed:articleTitle |
Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|